Skip to main content

ADVERTISEMENT

Maria Fernanda Zuliani Mauro, MD

Original Contribution
02/28/2017
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective,...
02/28/2017
Journal of Invasive Cardiology